Blocking Peli1 can confer protective effects in numerous diseases; however, exploring Peli1 agonists remains an intriguing area of investigation, as they could potentially enhance the protective effects of Peli1 in diseases such as SLE. This evidence concerns the gene PELI1 and systemic lupus erythematosus.